CSIMarket
 


Ptc Therapeutics inc   (PTCT)
Other Ticker:  
 
 

PTCT's Net Cash Flow Growth by Quarter and Year

Ptc Therapeutics Inc 's Net Cash Flow results by quarter and year




PTCT Net Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 428.87 175.41 -0.10 -225.16
III Quarter September -43.09 -53.73 12.47 275.51
II Quarter June -9.10 22.57 30.72 35.17
I Quarter March -62.33 -45.54 -62.18 -164.74
FY   314.35 98.71 -19.09 -79.22



PTCT Net Cash Flow fourth quarter 2023 Y/Y Growth Comment
Ptc Therapeutics inc reported Net Cash Flow surge of 144.5% year on year in the fourth quarter 2023, to $ 428.87 millions, this is lower than Ptc Therapeutics Inc 's recent average Net Cash Flow surge of 866.61%.

Looking into fourth quarter 2023 results within Major Pharmaceutical Preparations industry 7 other companies have achieved higher Net Cash Flow growth. While Ptc Therapeutics Inc ' s Net Cash Flow doubling of 144.5% ranks overall at the positon no. 274 in the fourth quarter 2023.




PTCT Net Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December 144.5 % - - -
III Quarter September - - -95.47 % -16.49 %
II Quarter June - -26.53 % -12.65 % 11.12 %
I Quarter March - - - -
FY   218.46 % - - -

Financial Statements
Ptc Therapeutics Inc 's fourth quarter 2023 Net Cash Flow $ 428.87 millions PTCT's Income Statement
Ptc Therapeutics Inc 's fourth quarter 2022 Net Cash Flow $ 175.41 millions Quarterly PTCT's Income Statement
New: More PTCT's historic Net Cash Flow Growth >>


PTCT Net Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - -59.41 % 683.37 %
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   218.46 % - - -




Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #8
Healthcare Sector #24
Overall #274

Net Cash Flow Y/Y Growth Statistics
High Average Low
17783.28 % 866.61 % -202.95 %
(Dec 31 2017)   (Sep 30 2016)
Net Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #8
Healthcare Sector #24
Overall #274
Net Cash Flow Y/Y Growth Statistics
High Average Low
17783.28 % 866.61 % -202.95 %
(Dec 31 2017)   (Sep 30 2016)

Net Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Ptc Therapeutics Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PTCT's IV. Quarter Q/Q Net Cash Flow Comment
IV. Quarter 2023Periodic Ptc Therapeutics inc in the circumstances net cash outflow of $ 428.87 millionsPeriodic circumstances have added to Ptc Therapeutics inc 's restoration of profitability, as PTCT clinchesNet Cash Flow of $ 428.87 millions in the IV. Quarter 2023 coming of net cash outflow-43.09 millions in the third quarter. Ptc Therapeutics inc announced in the IV. Quarter 2023 Net Cash Flow of $ 428.87 millions compare to net cash outflow recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Ptc Therapeutics inc achieved highest sequential Net Cash Flow growth. While Ptc Therapeutics Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PTCT's IV. Quarter Q/Q Net Cash Flow Comment
IV. Quarter 2023Cyclical Ptc Therapeutics inc in the influence net cash outflow of $ 428.87 millionsCyclical influence have led to Ptc Therapeutics inc 's return to positive trends, as PTCT deliverNet Cash Flow of $ 428.87 millions in the IV. Quarter 2023 coming of net cash outflow-43.09 millions in the third quarter. Ptc Therapeutics inc announced in the IV. Quarter 2023 Net Cash Flow of $ 428.87 millions compare to net cash outflow recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Ptc Therapeutics inc achieved highest sequential Net Cash Flow growth. While Ptc Therapeutics Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Ptc Therapeutics Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Net Cash Flow 12 Months Ending $ 314.36 $ 60.90 $ 50.25 $ 81.92 $ 98.71
Y / Y Net Cash Flow Growth (TTM) 218.48 % - - - -
Year on Year Net Cash Flow Growth Overall Ranking # 138 # 0 # 0 # 0 # 0
Seqeuential Net Cash Flow Change (TTM) 416.2 % 21.19 % -38.66 % -17.01 % -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 274 # 150 # 373 # 166 # 0




Cumulative Net Cash Flow growth Comment
Although Ptc Therapeutics Inc 's Annual Net Cash Flow growth year on year were below company's average 866.61% , Net Cash Flow announced in the Dec 31 2023 period, show improvement in Net Cash Flow trend, to cumulative trailing twelve month growth of 218.48% year on year, from % in Sep 30 2023.

Among companies within the Healthcare sector 15 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 0 to 138.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
17783.28 %
866.61 %
-202.95 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 8
Healthcare Sector # 16
Overall # 138

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
17783.28 %
866.61 %
-202.95 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 24
S&P 500 # 274
Cumulative Net Cash Flow growth Comment
Although Ptc Therapeutics Inc 's Annual Net Cash Flow growth year on year were below company's average 866.61% , Net Cash Flow announced in the Dec 31 2023 period, show improvement in Net Cash Flow trend, to cumulative trailing twelve month growth of 218.48% year on year, from % in Sep 30 2023.

Among companies within the Healthcare sector 15 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 0 to 138.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
17783.28 %
866.61 %
-202.95 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 8
Healthcare Sector # 16
Overall # 138

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
17783.28 %
866.61 %
-202.95 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 24
S&P 500 # 274




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
PTCT's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for PTCT's Competitors
Net Cash Flow Growth for Ptc Therapeutics Inc 's Suppliers
Net Cash Flow Growth for PTCT's Customers

You may also want to know
PTCT's Annual Growth Rates PTCT's Profitability Ratios PTCT's Asset Turnover Ratio PTCT's Dividend Growth
PTCT's Roe PTCT's Valuation Ratios PTCT's Financial Strength Ratios PTCT's Dividend Payout Ratio
PTCT's Roa PTCT's Inventory Turnover Ratio PTCT's Growth Rates PTCT's Dividend Comparisons



Companies with similar Net Cash Flow doubling for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Dec 31 2023
Healthcare Services Group Inc 246.33%$ 246.329 millions
Morphosys Ag226.46%$ 226.456 millions
3m Company215.94%$ 215.936 millions
Artivion Inc 206.86%$ 206.858 millions
Envista Holdings Corporation201.56%$ 201.563 millions
Bristol myers Squibb Company188.82%$ 188.816 millions
Novocure Limited187.30%$ 187.300 millions
Alpha Pro Tech Ltd 186.55%$ 186.546 millions
Lemaitre Vascular Inc 179.96%$ 179.964 millions
Charles River Laboratories International inc 163.93%$ 163.925 millions
Stryker Corp162.03%$ 162.028 millions
Ptc Therapeutics inc 144.49%$ 144.492 millions
National Healthcare Corp114.37%$ 114.371 millions
Nature s Sunshine Products inc 107.91%$ 107.907 millions
Exact Sciences Corporation105.45%$ 105.454 millions
Cadre Holdings Inc 104.55%$ 104.555 millions
Amedisys Inc 97.80%$ 97.799 millions
Bausch Health Companies Inc 93.62%$ 93.617 millions
Privia Health Group Inc 90.12%$ 90.121 millions
Fonar Corporation89.37%$ 89.370 millions
Adaptimmune Therapeutics Plc86.73%$ 86.732 millions
Belite Bio Inc86.17%$ 86.171 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com